According to research from a U.K.-based cancer organization, people are twice as likely to live at least 10 years after a cancer diagnosis than they were 40 years ago.
Thanks to earlier detection, improved screening and innovative treatments, certain types of cancer are becoming more manageable than before. While the paradigm is shifting, cancer still remains one of the leading causes of death worldwide.
Medical professionals are now reviewing their approach to cancer care — which includes diagnostics and treatment innovation. A new approach ultimately needs to put the patient at the heart of care.
Astellas Pharma Inc., in partnership with CNBC Catalyst, hosted a special panel event at TEDMED 2017 in Palm Springs, California, to discuss and share insights into these important topics. The event explored the latest tools, techniques and technology innovations that can be applied today, tomorrow and in the future to improve care and outcomes for people living with cancer.
This panel event was a collaboration between Astellas and CNBC Catalyst. Astellas had no influence over the panel discussion at this event, nor were Astellas products discussed.